Artisan Small Cap Fund Reduced its Stake in Halozyme Therapeutics (HALO). Here’s Why
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” fourth quarter 2024 investor letter ...
Nasdaq23d
HALO Quantitative Stock Analysis
HALOZYME THERAPEUTICS, INC. (HALO) is a mid-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the ...